Research priorities in spasmodic dysphonia.
D019274:Botulinum Toxins, Type A / Q000008:administration & dosage; D006801:Humans; D007828:Laryngoscopy; D009465:Neuromuscular Agents / Q000008:administration & dosage; D012009:Recurrent Laryngeal Nerve / Q000601:surgery; D012106:Research; D012307:Risk Factors; D014832:Voice Disorders / Q000175:diagnosis / Q000453:epidemiology / Q000503:physiopathology / Q000601:surgery
D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A